TNNC1 and cancer: We observed that TNNC1 is highly expressed in erlotinib resistance datasets, a finding consistent with the pattern proposed in previous studies where genes associated with drug resistance often exhibit low expression in cancer tissues but high expression in resistant cells (15, 40).